FDA investigates varenicline adverse events
The US FDA is evaluating post-marketing adverse events after aggressive and erratic behaviour led to the death of an individual who took the drug in an attempt to quit smoking. Click here to read more.
I’m available for freelance work at competitive rates. If you need accurate, authoritative writing or editing on these and other topics, contact me by email at gmatkin@gmail.com.
In addition to my role as clinical and CPD editor at Chemist+Druggist, I also commission educational features for the pharmacy counter staff magazine OTC’s Counterpart Plus series.
Up to now I have usually commissioned other people to write these features, but when family problems made it difficult for one of our regular writers to turn in their copy on time, I stepped in at the last moment and wrote this piece on sexual health.
With the housing shortage, the credit crunch, and the state of the environment, you’d think today’s youngsters didn’t need anything else to worry about. But there is at least one other big issue they need to take very seriously indeed: sexually transmitted infections. We’re living in a new and very different world. A generation ago, no-one had heard of herpes or HIV, and chlamydia was still little known - but in young people today some of these infections are reaching frightening proportions, and bringing disease, infertility and, frequently, broken relationships and families. These are issues for older people too, but the spread of these diseases is far worse in the young. Click here to read on…
Could you use copy like this for your publication or website? If so, contact me by email at gmatkin@gmail.com.
Recent features on pharmaceutical marketing:
•UK clinical trials: on the mend?, Pharmafocus feature on the renaissance of clinical research in the UK
•The NHS and pharma: Let’s work together, Pharmafocus feature on ways in which joint working can benefit both pharma and NHS organisations
•Med Ed comes of age, Pharmafocus feature on medical education
Need a top class medical journalist? Contact me by email at gmatkin@gmail.com.
One of my key responsibilities at Chemist+Druggist is directing, commissioning and editing the educational Update series. I also write many clinical news stories. Some typical examples recently included this piece about how diabetes services are failing patients, and this interesting development in the long running glitazones debate.
Contact me by email at gmatkin@gmail.com.
